Tag: trastuzumabHerceptin

Trastuzumab (Herceptin): A monoclonal antibody used to treat HER2/neu overexpressing (HER2+) breast cancer. Trastuzumab works by binding to the HER2/neu receptor, thereby reducing the effects of overexpression of HER2

Articles

News

05/01/16
Six-month delay in starting Herceptin linked to reduced survival in HER2+ breast cancer
07/22/12
Inflammation can contribute to resistance to Herceptin
12/01/11
Herceptin plus anthracycline chemotherapy greatly increases risk of heart damage
10/06/11
Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
03/19/11
Treatment with Herceptin for one year improves survival in women with HER2+ breast cancer

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap